Why did CureVac stock slip today? Declining market for COVID vaccines

Jan. 31, 2023 6:21 PM ETCureVac N.V. (CVAC)PFEBy: Jonathan Block, SA News Editor3 Comments

Elon Musk Announces Visit To Germany

Christian Kaspar-Bartke

  • CureVac (NASDAQ:CVAC) shares dropped ~7% Tuesday likely due to comments Pfizer (PFE) made earlier in the day that it expects a 64% drop in revenue from its COVID-19 vaccine.
  • CureVac (CVAC) is developing its own mRNA COVID vaccine, and reported positive phase 1 results.
  • However, given Pfizer's (PFE) comments on a declining COVID vaccine market, CureVac's (CVAC) shot could become available too little, too late.
  • In 2023, Pfizer (PFE) expects demand for its COVID vaccine of 65M, compared to 92M doses in 2022.
  • Check out Seeking Alpha contributor Derek Lowe's recent assessment of CureVac (CVAC).

Recommended For You

Comments (3)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.